Literature DB >> 14511458

Three-year follow-up for virtual reality exposure for fear of flying.

Brenda K Wiederhold1, Mark D Wiederhold.   

Abstract

Thirty participants who had been treated for aviophobia with virtual reality graded exposure therapy with physiological monitoring and visual feedback (VRGETpm), virtual reality graded exposure therapy with physiological monitoring only (VRGETno), or imaginal exposure therapy (visualization) with physiological monitoring only (IET) between January 1998 and January 1999 were contacted in January 2002 for a 3-year posttreatment follow-up assessment. Of the participants in the VRGETpm group who had flown successfully by the end of treatment, all had maintained their ability to fly at follow-up. Of the participants in the VRGETno group who had flown successfully by the end of treatment, two were no longer able to fly. Of the participants in the IET group who had flown successfully, all were still able to fly. It appears that the addition of teaching self-control via visual feedback of physiological signals may serve to maintain treatment gains in long-term follow-up.

Entities:  

Mesh:

Year:  2003        PMID: 14511458     DOI: 10.1089/109493103322278844

Source DB:  PubMed          Journal:  Cyberpsychol Behav        ISSN: 1094-9313


  10 in total

1.  Use of skills learned in CBT for fear of flying: managing flying anxiety after September 11th.

Authors:  Simon Kim; Frances Palin; Page Anderson; Shannan Edwards; Gretchen Lindner; Barbara Olisov Rothbaum
Journal:  J Anxiety Disord       Date:  2007-02-23

Review 2.  The Use of Virtual Reality Technology in the Treatment of Anxiety and Other Psychiatric Disorders.

Authors:  Jessica L Maples-Keller; Brian E Bunnell; Sae-Jin Kim; Barbara O Rothbaum
Journal:  Harv Rev Psychiatry       Date:  2017 May/Jun       Impact factor: 3.732

3.  Virtual reality for obsessive-compulsive disorder: past and the future.

Authors:  Kwanguk Kim; Chan-Hyung Kim; So-Yeon Kim; Daeyoung Roh; Sun I Kim
Journal:  Psychiatry Investig       Date:  2009-07-08       Impact factor: 2.505

Review 4.  Virtual reality in mental health : a review of the literature.

Authors:  Lynsey Gregg; Nicholas Tarrier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-03-12       Impact factor: 4.519

5.  Presence and rehabilitation: toward second-generation virtual reality applications in neuropsychology.

Authors:  Giuseppe Riva; Fabrizia Mantovani; Andrea Gaggioli
Journal:  J Neuroeng Rehabil       Date:  2004-12-08       Impact factor: 4.262

Review 6.  Virtual reality in the assessment, understanding, and treatment of mental health disorders.

Authors:  D Freeman; S Reeve; A Robinson; A Ehlers; D Clark; B Spanlang; M Slater
Journal:  Psychol Med       Date:  2017-03-22       Impact factor: 7.723

7.  Action-Centered Exposure Therapy (ACET): A New Approach to the Use of Virtual Reality to the Care of People with Post-Traumatic Stress Disorder.

Authors:  Sorelle Audrey Kamkuimo Kengne; Mathilde Fossaert; Benoît Girard; Bob-Antoine J Menelas
Journal:  Behav Sci (Basel)       Date:  2018-08-16

8.  Enhanced location tracking in sensor fusion-assisted virtual reality micro-manipulation environments.

Authors:  John David Prieto Prada; Jintaek Im; Hyondong Oh; Cheol Song
Journal:  PLoS One       Date:  2021-12-28       Impact factor: 3.240

9.  Is Continued Improvement After Automated Virtual Reality Exposure Therapy for Spider Phobia Explained by Subsequent in-vivo Exposure? A First Test of the Lowered Threshold Hypothesis.

Authors:  Philip Lindner; Peter Dafgård; Alexander Miloff; Gerhard Andersson; Lena Reuterskiöld; William Hamilton; Per Carlbring
Journal:  Front Psychiatry       Date:  2021-05-20       Impact factor: 4.157

10.  Automated psychological therapy using immersive virtual reality for treatment of fear of heights: a single-blind, parallel-group, randomised controlled trial.

Authors:  Daniel Freeman; Polly Haselton; Jason Freeman; Bernhard Spanlang; Sameer Kishore; Emily Albery; Megan Denne; Poppy Brown; Mel Slater; Alecia Nickless
Journal:  Lancet Psychiatry       Date:  2018-07-11       Impact factor: 27.083

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.